BRIEF

on NEOVACS (EPA:ALNEV)

NEOVACS: Update on the number of shares and voting rights

Stock price chart of NEOVACS (EPA:ALNEV) showing fluctuations.

On May 16, 2025, Neovacs, a biopharmaceutical company based in Suresnes and listed on Euronext Growth Paris, published information regarding the composition of its share capital. As of April 30, 2025, the total number of shares and gross and net voting rights stands at 59,870,096.

The company also specifies the number of shares issued each month since the beginning of 2025. For example, in April, this number reached 55,038,017, including shares issued from OCEANE and ORA bonds.

It is recalled that this type of financial transaction, which can lead to a dilution of capital, requires increased vigilance on the part of investors due to the potential downward pressure on the share price.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all NEOVACS news